LAS VEGAS, Nov. 19, 2025 — Odyssey Health, Inc., a medical device company (OTCQB: ODYY), has entered into a multi-million-dollar, nine-year maintenance service contract for a commercial medical property. The company also secured a financing facility of up to $25 million.
According to a press release, the long-term maintenance agreement will create a stable, recurring revenue stream, marking a significant step in Odyssey’s ongoing transition toward sustainable, cash-generating operations. The initial tranche of the financing facility, $500,000, will be directed toward advancing Odyssey’s recently announced BreastCheck® sub-licensing program.
Michael Redmond, President and CEO of Odyssey Health, Inc., stated that the agreement delivers predictable monthly cash flow and underscores the company’s commitment to building recurring, scalable revenue. Redmond added that the financing facility further positions the company to capitalize on growth opportunities across its diversified portfolio and drive long-term shareholder value.
The new facility services contract and financing facility follow a series of strategic transactions that highlight Odyssey’s strengthening financial position and operational momentum. Most recently, Odyssey entered into a sub-licensing agreement for exclusive, worldwide rights to BreastCheck®, a rapid, non-invasive screening test for breast abnormalities, a product of Davion Healthcare PLC. The BreastCheck® test can be performed at home in approximately 15 minutes, providing immediate results that help identify potential breast abnormalities at an early stage.
BreastCheck® averages temperature at three areas on each breast. By comparing the temperature of corresponding areas of one breast to the other and entering the results on the BreastCheck® Mobile App, results can be interpreted immediately. The screening test is intended to be an adjunct to established procedures for the detection of breast disease, such as clinical breast examination and mammography.
The company states this innovative technology aligns with Odyssey’s mission to deliver accessible, life-saving diagnostic solutions that can meaningfully impact patient outcomes worldwide.
Investor Relations
Odyssey Health, Inc.
Email: info@odysseyhealthinc.com
Source: Odyssey Health, Inc.
